Synbio Tech Inc. (1295) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Synbio Tech Inc. (1295:TWSE), powered by AI.

Current Price
$50.50
Sector
Healthcare
What is the Synbio Tech Inc. stock price forecast?

Synbio Tech Inc. is currently trading at $50.50. View real-time AI analysis on Alpha Lenz.

What is Synbio Tech Inc. insider trading activity?

View the latest insider trading data for Synbio Tech Inc. on Alpha Lenz.

What is Synbio Tech Inc.'s P/E ratio?

View Synbio Tech Inc.'s valuation metrics on Alpha Lenz.

Synbio Tech Inc.

TWSE · 1295
NT$50.50+1.90(+3.91%)
Ask about Synbio Tech Inc.'s future dividend policy...
Alpha Chat Insight

Synbio Tech Inc.'s ROE is 14.6%. Explore profitability and growth together.

Ask for details

Company Overview

Synbio Tech Inc. is a biotechnology company specializing in the development, research, and manufacturing of probiotic and postbiotic solutions. Established in 2000 and headquartered in Kaohsiung, Taiwan, the company plays a central role in the pharmaceuticals and biotech sector, with a focus on innovative microbial products tailored for both human and animal health. Synbio Tech is recognized for its expertise in lactic acid bacteria, producing a diverse range of products such as lactic acid bacteria powders, starter cultures, fermentation broths, and functional beverages. These are used extensively in functional human health foods, fermented milk drinks, pet nutrition, and as feed additives for livestock and aquaculture—offering sustainable and science-backed alternatives in food production and animal care. With a comprehensive microbial culture collection bank and dedicated microbiome research facilities, Synbio Tech Inc. positions itself as a leader in advancing next-generation probiotic technologies, supporting global food safety and wellness trends across over 30 markets worldwide.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.04BRevenue
0.00Shares Out
0Employees

Margins

53.45%Gross
28.35%EBITDA
19.10%Operating
19.48%Pre-Tax
16.94%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

12.00%Rev 3Yr
7.09%Rev 5Yr
24.90%Op Inc 3Yr
4.58%Op Inc 5Yr
23.90%Net Inc 3Yr
5.95%Net Inc 5Yr

Returns

6.48%ROA
14.61%ROE
7.92%ROIC

Financial Health

NT$269.94MCash & Cash Equivalents
NT$1.49BNet Debt
131.95%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Synbio Tech Inc. (ticker: 1295) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 50.5 with a P/E ratio of -x and P/B of -x.

ROE is 14.61% and operating margin is 19.10%. Annual revenue is $1.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Synbio Tech Inc. (1295) Stock Forecast 2026 $50.50 — Price, Financials & Analyst Targets | Alpha Lenz